Waive
PrivateLast Round
Accelerator
Mar 10, 2026
Total Funding Raised
$10,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Waive operates in Healthcare & Life Sciences and is based in Sudbury, Ontario. Its latest recorded funding round was an Accelerator round in March 2026.
Waive is a healthtech company that provides intelligent automation tools for medical clinics to streamline administrative tasks, manage patient communication, and automate paperwork.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Workflow Automation, Medical AI, Patient Engagement, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Waive Comparables
Compare Waive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phelix.ai | 87% | |
| Cortico Health Technologies | 82% | |
| WELL Health Technologies | 80% |
For institutional investors. Book with your work email.
Waive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 10, 2026 | ||||
| VC Round | Apr 9, 2024 | ||||
| Seed | Oct 16, 2023 | ||||
| Accelerator | Aug 20, 2020 |
For institutional investors. Book with your work email.
Waive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dunin-Deshpande Queen's Innovation Centre | Accelerator |
| Ripple Ventures | Seed |
| Northern Ontario Angels | Seed |
| Google for Startups Accelerator | Accelerator |
| Enactus Canada | Accelerator |
| Transform VC | Seed |
| Archangel Network of Funds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Grew 23% QoQ, from 13 to 16 employees.
- Jun 17, 2026
Grew 31% QoQ from 13 to 17 employees.
For institutional investors. Book with your work email.
Waive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Waive's valuation, stock price, and market status.
Is Waive a public or private company?
Waive is a private company.
What is the current stock price of Waive?
Waive is a private company, so its shares have no public market price. Caplight tracks Waive's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Waive worth (valuation)?
Valuation information for Waive is not publicly available.
Can I buy Waive stock?
Waive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Waive's last funding round?
Waive's most recent funding round was Accelerator on March 10, 2026.
Who are the main investors in Waive?
Key investors in Waive include Dunin-Deshpande Queen's Innovation Centre, Ripple Ventures, Northern Ontario Angels, Google for Startups Accelerator, Enactus Canada.
Will Waive IPO soon?
No public IPO plans have been announced for Waive.
How can I track Waive secondary market activity?
Caplight tracks bids, offers, and trades in Waive's shares on secondary markets.